Skip to main content
无锡晶海 logo

无锡晶海 — Investor Relations & Filings

Ticker · 920547 Beijing Stock Exchange Manufacturing
Open in API
Filings indexed 300 across all filing types
Latest filing 2024-04-21 Notice of Dividend Amou…
Country CN China
Listing Beijing Stock Exchange 920547

About 无锡晶海

https://www.chinaaminoacid.com/

Wuxi Jinghai Amino Acid Co., Ltd. specializes in the research, development, and large-scale production of high-purity amino acids through microbial fermentation. The company’s core product portfolio includes L-Isoleucine, L-Valine, L-Leucine, L-Proline, and L-Threonine, which serve as critical raw materials for the pharmaceutical, nutritional, and food processing sectors. Utilizing advanced biotechnological processes, the firm maintains rigorous quality control standards, holding certifications such as GMP, ISO, HALAL, and KOSHER. Its products are primarily utilized in the formulation of parenteral nutrition, specialized medical foods, and high-end supplements. The company focuses on technological innovation to optimize fermentation yields and purity levels, positioning itself as a key supplier in the global amino acid supply chain.

Recent filings

Filing Released Lang Actions
关于公司2023年度权益分派预案的公告
Notice of Dividend Amount Classification · 95% confidence The document is titled as an "Annual Equity Distribution Plan Announcement" for the year 2023 by Wuxi Jinghai Amino Acid Co., Ltd. It details the company's profit distribution plan including cash dividends and stock dividends, referencing the audited 2023 annual report but not containing the full annual report itself. It includes information about board and supervisory approvals, independent director opinions, and company articles of association related to profit distribution. The document is an announcement of a dividend distribution plan (equity distribution plan) rather than the actual annual report or earnings release. It is not a full financial report but a specific announcement about dividend amounts and distribution methods. Therefore, it fits best under the category "Notice of Dividend Amount (DIV)" which covers announcements of dividend amounts, payment dates, and details for shareholders. The document length is under 5,000 characters, consistent with an announcement rather than a full report.
2024-04-21 Chinese
东方证券承销保荐有限公司关于无锡晶海氨基酸股份有限公司2024年度日常关联交易预计的核查意见
Regulatory Filings Classification · 95% confidence The document is a verification opinion from the underwriting and sponsorship institution (东方证券承销保荐有限公司) regarding the expected related party transactions for the year 2024 of 无锡晶海氨基酸股份有限公司. It includes detailed descriptions of the related party transactions, their amounts, the parties involved, the approval process by the board and supervisory committee, and the fairness and compliance of the transactions. The document is not a full financial report but rather a regulatory compliance and verification statement related to ongoing business activities and governance. It does not contain comprehensive financial statements or quarterly/yearly financial results. The document length is 2864 characters, which is relatively short and focused on a specific regulatory compliance matter. This fits best under Regulatory Filings (RNS), which is the fallback category for miscellaneous filings that do not fit other specific categories such as Annual Report, Interim Report, or Audit Report. Therefore, the classification is Regulatory Filings (RNS) with high confidence.
2024-04-21 Chinese
2023年年度报告
Annual Report Classification · 100% confidence The document is titled '年度报告 2023' which translates to 'Annual Report 2023'. It contains detailed sections typical of an annual report, including company overview, financial data and indicators, management discussion and analysis, major events, shareholder information, financing and profit distribution, board and senior management information, industry information, corporate governance, internal controls, and financial accounting reports. The document includes audited financial statements, management certifications, and an audit opinion with an unqualified opinion from the accounting firm. The report covers the full fiscal year from January 1, 2023, to December 31, 2023. The length of the document is substantial (15,000 characters), indicating it is the full report rather than an announcement. Therefore, this document fits the definition of an Annual Report (10-K). FY 2023
2024-04-21 Chinese
2023年度募集资金存放与使用情况的专项报告
Capital/Financing Update Classification · 95% confidence The document is titled as a "2023年度募集资金存放与使用情况的专项报告" which translates to a "Special Report on the Deposit and Use of Raised Funds for the Year 2023." It details the amount of funds raised through a public stock issuance, the usage of these funds during the year, the balance remaining, and the management and regulatory compliance related to these funds. It includes detailed financial figures about the raised capital, usage, and bank accounts holding the funds. The document also contains auditor verification and sponsor opinions on the compliance of fund usage. This type of document is a specialized report focused on capital raising and the use of those funds, which fits the category of "Capital/Financing Update" (CAP). It is not a full annual report or interim report, nor is it a simple announcement or certification. The length and detail confirm it is a substantive report on financing activities.
2024-04-21 Chinese
关于与控股股东及银行签订资金共管协议进展的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding the progress of a fund custody agreement signed between the company, its controlling shareholder, and a bank. It details the signing of agreements, the deposit of funds into a joint custody account, and references a previous announcement with a specific announcement number. The document is short (910 characters) and primarily provides an update on a financing-related arrangement involving funds and bank accounts. It does not contain financial statements, audit information, or detailed financial results. It is not a full report but an update on capital management and financing activities. Therefore, it fits best under Capital/Financing Update (CAP).
2024-04-21 Chinese
独立董事2023年度述职报告-李苒洲
Board/Management Information Classification · 95% confidence The document is titled as an "Independent Director 2023 Annual Work Report" for Wuxi Jinghai Amino Acid Co., Ltd. It details the independent director's background, attendance at board meetings, opinions on various company matters, and overall evaluation of their duties during the 2023 fiscal year. The content focuses on the independent director's activities, compliance with regulations, and governance role rather than financial results or audit findings. There is no indication that this is a full annual report, audit report, or earnings release. Instead, it is a report on the independent director's work and governance role, which fits best under Board/Management Information (MANG) as it relates to management and board-level disclosures about director duties and governance activities. The document length is 4201 characters, which is sufficient for a detailed report but not a full financial report. Therefore, the classification is MANG with high confidence.
2024-04-21 Chinese

Browse filings by year

4 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.